AbClon
Your hope, we keep
Seoul, South Korea · Founded 2010 · $26.1M raised
- Headquarters
- Seoul
- Founded
- 2010
- Business Model
- B2B
- Website
- abclon.com
- Total Funding
- $26.1M
- Last Round
- $18.2M Convertible NoteOct 2025
- Rounds
- 2
About
AbClon is a South Korean biopharmaceutical company founded in 2010 in Seoul that specializes in developing next-generation antibody-based cancer therapeutics, including CAR-T cell therapies, bispecific antibodies, and novel epitope-targeting antibody drugs. Its proprietary platforms — CAR-T, NEST (Novel Epitope Screening Technology), and AffiMab — are designed to address both hematologic malignancies and solid tumors. AbClon's lead CAR-T asset AT101 is in Phase 2 clinical trials in Korea for blood cancers, and its antibody AC101 has received Orphan Drug Designation from the European Commission for gastric cancer. The company has attracted significant strategic investment, including a ₩10 billion stake from pharmaceutical firm Chong Kun Dang, and has licensed assets internationally including to China's Henlius Biotech.
Summary
AbClon is a Biotech company based in Seoul, South Korea, founded in 2010. It has raised $26.1M in total across 2 rounds, most recently a $18.2M Convertible Note round in Oct 2025. Investors include DSC Investment and Paratus Investment.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2025
Sign up to see all 2 rounds
Convertible Note through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/abclon"><img src="https://indexed.vc/api/badge/company/abclon" alt="AbClon on Indexed.vc" width="260" height="76" /></a>